Insider Transactions in Q3 2025 at Alumis Inc. (ALMS)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 29
2025
|
Mark Christopher Bradley Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,750
+35.44%
|
-
|
|
Jul 29
2025
|
Jorn Drappa Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,450
+47.22%
|
-
|
|
Jul 29
2025
|
David M Goldstein Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+48.12%
|
-
|
|
Jul 29
2025
|
Roy C. Hardiman Chief Business & Strategy Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+11.95%
|
-
|
|
Jul 29
2025
|
John R. Schroer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+50.0%
|
-
|
|
Jul 29
2025
|
Derrick Richardson SVP, People and Culture |
BUY
Grant, award, or other acquisition
|
Direct |
42,800
+50.0%
|
-
|
|
Jul 29
2025
|
Sanam Pangali Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+47.37%
|
-
|